(1)
Laboratory Assessment of Liver Function in People Starting Antiretroviral Therapy With Dolutegravir or Efavirenz: A Cohort Study in Belo Horizonte, Brazil. RSD 2022, 11 (13), e74111335082. https://doi.org/10.33448/rsd-v11i13.35082.